By InvitationNot Applicable

Virtual Reality for Anxiety Relief in Infertile Women

Cyprus80 participantsStarted 2025-03-01

Plain-language summary

This study examines the impact of virtual reality (VR) applications on anxiety levels before and after embryo transfer procedures. The clinical trial will involve 80 participants, aged 18 to 50, who are receiving treatment at a healthcare facility in the Turkish Republic of Northern Cyprus (TRNC). The primary objective is to evaluate the effectiveness of VR as an intervention for reducing anxiety in individuals undergoing assisted reproductive treatments.

Who can participate

Age range18 Years – 50 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Volunteered to participate in the research, * 18-50 years old * No vision and hearing problems, * Not disoriented in time and place, * Primary infertile * Not having communication problem * Can read \& write * No mental pathological disease Exclusion Criteria: * Secondary infertility * Having experienced bleeding, miscarriage, etc. after embryo transfer, * Difficulty communicating, * Problems such as migraine, vertigo, dizziness, * Patients who wear prescription glasses and have vision problems without glasses * Refused to participate in the research * Patients with psychiatric pathology

What they're measuring

Anxiety level of the women who went through embryo transfer.

Timeframe: 1 year

Trial details

NCT IDNCT07020975

SponsorCyprus Aydin University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-03-01

View on ClinicalTrials.gov More Anxiety trials